
The Future of Medicine Shaped
by Cutting-Edge Cell Design Technology
The Research Institute for Cell Design Medical Science (RICeD) aims to become an international research and development center that successively creates seeds for the next-generation cell and gene therapies, through innovative cell design technologies, which are core strength of Yamaguchi University. RICeD also aims to promote the practical application of cutting-edge immunotherapy and genome medicine based on our innovative technologies, to develop treatments for intractable diseases such as cancer and genetic diseases, and to apply and verify these innovative therapies in companion animals. By creating an active cycle in which knowledge gained in humans and companion animals is fed back to each other, RICeD will endeavor to form a drug discovery ecosystem through the social implementation of the created technologies, contribute to local communities and foster human resources through the creation of industries, and extend the healthy lifespan of both humans and companion animals.
- ALL
- News
- Thesis
- Recruiting
.png)
News
2025.09.02
*Announcement* In-House Seminar Held
.png)
News
2025.09.01
*Notice* The research project by Lecturer Isao Tamura (Division of Advanced Genome Editing Therapy) has been selected for the “Emergent Research Support Program” by the Japan Science and Technology Agency (JST).
-1.png)
News
2025.09.01
*Notice* Kyushu University Bridge Research Program (University-based Medical Startup Support Program) Seeds S0: Our institute member has been selected

News
2025.08.27
*Announcement* External Lecturer Seminar Held

News
2025.08.22
*Announcement* Co-hosted Seminar Held

News
2025.08.21
*Announcement* On Friday, October 3, we will hold a symposium titled “The Integration of Medicine and Veterinary Medicine: Opening Up New Horizons for Human and Animal Health.”

News
2025.08.20
*Announcement* We participated in the “Science Exhibition Connecting Me and the Future” hosted by the Ministry of Education, Culture, Sports, Science and Technology, held at the Osaka-Kansai Expo venue.
.png)
News
2025.08.19
*Announcement* Announcement An in-house seminar will be held on September 1 (Mon).

Thesis
2025.09.29
Lactic acid regulates antitumor immunity in canine invasive urothelial carcinoma

Thesis
2025.09.08
Impact of Frailty on Major Adverse Cardiovascular Events in Chronic Obstructive Pulmonary Disease

Thesis
2025.08.06
Comparison of Post Ablation Left Atrial Volume Index versus Left Atrial ReverseRemodeling for Prognostic Events in Persistent Atrial Fibrillation

Thesis
2025.07.30
The future of Kawasaki disease management: data-driven innovations from bedside to bench and back again

Thesis
2025.07.28
Unsupervised identification of asthma symptom subtypes supports treatable traits approach

Thesis
2025.07.24
Wound-healing effects of frozen-thawed allogeneic fibroblast sheet transplantation and xenogeneic fibroblast cell sheet transplantation cultured on a new substrate/Development of Frozen-thawed Allogeneic Fibroblast Sheets for Esophageal Anastomotic Leakage

Thesis
2025.07.18
High-Concentration Hydrogen Delivery During Dialysis Using an Innovative Direct Dissolution Technique: In Vivo Kinetics in a Canine Model.

Thesis
2025.06.12
Riboflavin transporter: Evidence of a role as entry receptor for chimpanzee endogenous retrovirus
The article could not be found.

Thesis
2025.09.29
Lactic acid regulates antitumor immunity in canine invasive urothelial carcinoma

Thesis
2025.09.08
Impact of Frailty on Major Adverse Cardiovascular Events in Chronic Obstructive Pulmonary Disease
.png)
News
2025.09.02
*Announcement* In-House Seminar Held
-1.png)
News
2025.09.01
*Notice* Kyushu University Bridge Research Program (University-based Medical Startup Support Program) Seeds S0: Our institute member has been selected
.png)
News
2025.09.01
*Notice* The research project by Lecturer Isao Tamura (Division of Advanced Genome Editing Therapy) has been selected for the “Emergent Research Support Program” by the Japan Science and Technology Agency (JST).

News
2025.08.27
*Announcement* External Lecturer Seminar Held

News
2025.08.22
*Announcement* Co-hosted Seminar Held

News
2025.08.21
*Announcement* On Friday, October 3, we will hold a symposium titled “The Integration of Medicine and Veterinary Medicine: Opening Up New Horizons for Human and Animal Health.”
About RICeD
Request for Donations to RICeD
We are promoting the development of cutting-edge cancer immunotherapy to cure many patients.
We are also working to extend the healthy lifespan of both humans and companion animals by applying the world’s first genome editing technology to the treatment of genetic diseases in companion animals and applying the results to human medicine,
We are also working to extend the healthy lifespan of both humans and companion animals by applying the results of our research to human medicine.We sincerely ask for your support to achieve these goals and to continue to promote the practical application of our research results in society.
ー Follow us! ー